Suppr超能文献

同步和异时性结直肠肝转移:原发肿瘤位置对肝切除术后复发模式和生存的影响。

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection.

机构信息

Medical Oncology Unit, University Hospital of Parma.

Department of Medicine and Surgery - University of Parma.

出版信息

Acta Biomed. 2020 Dec 1;92(1):e2021061. doi: 10.23750/abm.v92i1.11050.

Abstract

BACKGROUND

Considerable differences in terms of prognosis exist between the right-sided (RCC) and the left-sided colon cancer (LCC). Aim of the work: In this study, we evaluated prognostic implications of primary tumor location (PTL) among patients who underwent curative-intent hepatectomy for synchronous (SM) and metachronous (MM) colorectal liver metastases (CRLM).

METHODS

The study population included all consecutive patients affected by CRLM scheduled for first liver resection at three Italian oncological centers.

RESULTS

A total of 204 patients who underwent CRLM resection were included, 50% with RCC. Synchronous lesions were prevalent (n=133, 65%). Median OS was respectively 40.3 months for SM-RCC, 53.5 months for SM-LCC, 64.5 months for MM-RCC and 81.6 months for MM-LCC. Patients with MM-LCC showed an OS better than patients with SM-RCC (p=0.008) and SM-LCC (p=0.002). PTL had no influence on RFS. RCC group had less recurrences (75% vs 86.5%), though further surgery with curative-intent was possible more in LCC group (29.3% vs 32.5%). Cox proportional hazards model analysis showed that age and the presence of SM vs MM was associated with a significantly higher hazard ratio (HR) for death (HR=1.024; 95%CI=1.005-1.043; p=0.011 and HR=2.010; 95%CI=1.328-3.043; p=0.001, respectively).

CONCLUSIONS

We confirmed that patients with CRLM and right-sided primary colon cancer experience worse survival after hepatic resection. The timing of metastasis has been revealed as important prognostic factor.

摘要

背景

右半结肠癌(RCC)和左半结肠癌(LCC)的预后存在显著差异。目的:本研究旨在评估原发肿瘤位置(PTL)对接受根治性肝切除术的同时性(SM)和异时性(MM)结直肠癌肝转移(CRLM)患者的预后意义。

方法

研究人群包括在意大利三个肿瘤中心接受首次肝切除术的所有连续 CRLM 患者。

结果

共纳入 204 例接受 CRLM 切除术的患者,其中 50%为 RCC。同时性病变更为常见(n=133,65%)。SM-RCC 的中位 OS 分别为 40.3 个月,SM-LCC 为 53.5 个月,MM-RCC 为 64.5 个月,MM-LCC 为 81.6 个月。MM-LCC 患者的 OS 优于 SM-RCC(p=0.008)和 SM-LCC(p=0.002)患者。PTL 对 RFS 无影响。RCC 组复发率较低(75% vs 86.5%),但 LCC 组进一步行根治性手术的可能性更大(29.3% vs 32.5%)。Cox 比例风险模型分析显示,年龄、SM 与 MM 的存在与死亡的风险比(HR)显著相关(HR=1.024;95%CI=1.005-1.043;p=0.011 和 HR=2.010;95%CI=1.328-3.043;p=0.001)。

结论

我们证实,接受肝切除术的 CRLM 患者和右侧原发性结肠癌患者的生存情况更差。转移的时间已被揭示为重要的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c8/7975968/4c314740b1ad/ACTA-92-61-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验